TP53 and neoplasm: p53 status has been reported to influence response to CDDP treatment in a number of models and consequently the p53 status of these two tumours were determined (Brown et al, 1993; Eliopoulos et al, 1995; Herod et al, 1996; O'Connor et al, 1997).